GIA
NMRD

GHP Investment Advisors’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

GHP Investment Advisors’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-400
Closed -$1K – 991
2022
Q2 		$1K Buy
+400
New +$1.28K ﹤0.01% 907

Other funds holding NMRD

TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

GHP Investment Advisors's NMRD Position: Q3 2022 in Review

GHP Investment Advisors sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q3 2022, closing a stake of 400 shares — an estimated $1K sold.

GHP Investment Advisors first reported a position in NMRD in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 20 funds tracked by Wall St. Rank hold NMRD as of Q3 2022.

  • GHP Investment Advisors reported no remaining Nemaura Medical, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • GHP Investment Advisors sold 400 Nemaura Medical, Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • GHP Investment Advisors first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • GHP Investment Advisors's Nemaura Medical, Inc. Common Stock position peaked at $1K in Q2 2022.
  • 20 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q3 2022.

Based on GHP Investment Advisors's 13F filing for Q3 2022, filed 28 Oct 2022.